Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $156.66 | 7 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Promega Corporation | $125.50 | 5 | $0 (2023) |
| BTG International, Inc. | $16.72 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $14.44 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $28.50 | 1 | Promega Corporation ($28.50) |
| 2022 | $74.50 | 3 | Promega Corporation ($74.50) |
| 2021 | $22.50 | 1 | Promega Corporation ($22.50) |
| 2018 | $31.16 | 2 | BTG International, Inc. ($16.72) |
All Payment Transactions
7 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/07/2023 | Promega Corporation | ONCOMATE MSI DX ANALYSIS SYSTEM (Device) | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: Oncology | ||||||
| 08/16/2022 | Promega Corporation | ONCOMATE MSI DX ANALYSIS SYSTEM (Device) | Food and Beverage | In-kind items and services | $28.00 | General |
| Category: Oncology | ||||||
| 06/03/2022 | Promega Corporation | ONCOMATE MSI DX ANALYSIS SYSTEM (Device) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: Oncology | ||||||
| 01/21/2022 | Promega Corporation | Lumit Dx SARS-CoV-2 (Device) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Infectious Disease | ||||||
| 08/06/2021 | Promega Corporation | Lumit Dx (Device) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Infectous Disease | ||||||
| 04/14/2018 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Oncology | ||||||
| 02/20/2018 | BTG International, Inc. | CROFAB (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: ANTI-VENOM | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 192 | 1,252 | $381,260 | $70,653 |
| 2022 | 10 | 651 | 1,070 | $188,776 | $27,479 |
| 2021 | 14 | 1,064 | 1,863 | $339,636 | $54,953 |
| 2020 | 10 | 943 | 1,623 | $298,230 | $49,027 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2023 | 169 | 1,189 | $368,590 | $67,438 | 18.3% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Office | 2023 | 11 | 32 | $8,640 | $2,384 | 27.6% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 12 | 31 | $4,030 | $831.73 | 20.6% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2022 | 220 | 461 | $115,250 | $13,739 | 11.9% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2022 | 39 | 45 | $15,750 | $2,956 | 18.8% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2022 | 26 | 77 | $12,936 | $2,552 | 19.7% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2022 | 27 | 100 | $6,000 | $2,229 | 37.1% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2022 | 61 | 78 | $6,240 | $2,153 | 34.5% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2022 | 50 | 68 | $12,240 | $1,489 | 12.2% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2022 | 95 | 97 | $3,880 | $953.98 | 24.6% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2022 | 86 | 88 | $12,320 | $781.85 | 6.3% |
| 88104 | Cell examination of body fluid, smears | Facility | 2022 | 15 | 24 | $2,880 | $518.34 | 18.0% |
| 88300 | Pathology examination of tissue using a microscope, limited examination | Facility | 2022 | 32 | 32 | $1,280 | $107.10 | 8.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2021 | 336 | 742 | $185,500 | $23,056 | 12.4% |
| 88307 | Pathology examination of tissue using a microscope, moderately high complexity | Facility | 2021 | 90 | 138 | $48,300 | $9,477 | 19.6% |
| 88360 | Microscopic genetic analysis of tumor, manual | Facility | 2021 | 37 | 167 | $28,056 | $5,849 | 20.8% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2021 | 112 | 160 | $12,800 | $4,678 | 36.6% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2021 | 40 | 163 | $9,780 | $3,869 | 39.6% |
| 88112 | Cell examination of specimen, selective cellular enhancement technique | Facility | 2021 | 79 | 109 | $19,620 | $2,522 | 12.9% |
| 88309 | Pathology examination of tissue using a microscope, high complexity | Facility | 2021 | 11 | 12 | $5,400 | $1,463 | 27.1% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2021 | 128 | 134 | $5,360 | $1,371 | 25.6% |
| 88304 | Pathology examination of tissue using a microscope, moderately low complexity | Facility | 2021 | 119 | 123 | $17,220 | $1,163 | 6.8% |
| 85060 | Blood smear interpretation by physician with written report | Facility | 2021 | 29 | 29 | $1,450 | $592.76 | 40.9% |
| 88312 | Special stained specimen slides to identify organisms including interpretation and report | Facility | 2021 | 15 | 17 | $1,700 | $378.59 | 22.3% |
| 88108 | Cell examination of specimen, concentration technique | Facility | 2021 | 16 | 17 | $2,040 | $319.77 | 15.7% |
About Dr. Robert Veve, MD
Dr. Robert Veve, MD is a Anatomic Pathology & Clinical Pathology healthcare provider based in Murrieta, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962466078.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Veve, MD has received a total of $156.66 in payments from pharmaceutical and medical device companies, with $28.50 received in 2023. These payments were reported across 7 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($156.66).
As a Medicare-enrolled provider, Veve has provided services to 2,850 Medicare beneficiaries, totaling 5,808 services with total Medicare billing of $202,112. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology & Clinical Pathology
- Other Specialties Cytopathology
- Location Murrieta, CA
- Active Since 04/14/2006
- Last Updated 11/16/2009
- Taxonomy Code 207ZP0102X
- Entity Type Individual
- NPI Number 1962466078
Products in Payments
- ONCOMATE MSI DX ANALYSIS SYSTEM (Device) $82.00
- Lumit Dx (Device) $22.50
- Lumit Dx SARS-CoV-2 (Device) $21.00
- CROFAB (Drug) $16.72
- TAGRISSO (Drug) $14.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.